Upgrade to SI Premium - Free Trial

Form EFFECT EyePoint Pharmaceuticals

October 31, 2023 6:06 AM
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: October 30, 2023 4:00 P.M.
Form: S-3
CIK: 0001314102
Company Name: EyePoint Pharmaceuticals, Inc.
File Number: 333-275125

Categories

SEC Filings

Next Articles